ERNA vs PH
Eterna Therapeutics Inc (ERNA) versus Parker-Hannifin Corporation (PH) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Parker-Hannifin Corporation (PH) is a specialty industrial machinery company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported PH revenue for 2025-06-30 was $19.85B. Net income was $3.53B. PH currently screens at market cap $91.89B and trailing P/E 27.7.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. PH currently screens at market cap $91.89B and trailing P/E 27.7.
Not investment advice. Open the ERNA and PH stock pages for the full models.
Not investment advice.